AzTrials
AzTrials

Hot Weather; Adverse EffectAim1NCT04767347

Renal Considerations in the Heat Stress Recommendations

A study testing 23.0°C WBGT - Fixed Work Rate, 25.5°C WBGT - Fixed Work Rate and 27.5°C WBGT - Fixed Work Rate in people with Hot Weather; Adverse Effect and Kidney Dysfunction, run by Indiana University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

An epidemic of chronic kidney disease is occurring in laborers who undertake physical work outdoors in hot conditions. The reason for this is unknown, but may be related to kidney dysfunction caused by increases in body temperature and dehydration. Read more about this study

Who is it for?
Ages 18 to 44 yearsHealthy volunteers can take part
What is being tested?
23.0°C WBGT - Fixed Work Rate, 25.5°C WBGT - Fixed Work Rate and 27.5°C WBGT - Fixed Work Rate
Could I receive a placebo?
No, everyone receives an active treatment
How many people
38 participants
Where
1 siteUnited States
Study dates
1 Mar 2021to 4 May 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 44 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Men and women
  • 18-44 y old
  • Body mass index ≤35.0 kg/m2
  • Self-reported to be healthy.

Who cannot join

  • Not within defined age range
  • Estimated glomerular filtration rate (eGFR) < 60 mL/min/1.73m2
  • Deemed highly active according to the physical activity questionnaire (i.e., >3500 MET*min/wk)
  • Body mass index >35.0 kg/m2
  • Current or history of any renal disease, heart disease, stroke, immune or autoimmune disease, and/or gastrointestinal disease/surgery
  • Hypertension during screening (systolic blood pressure >139 or diastolic blood pressure >89)
Show all 11Show fewer
  • Using medications that blunt the physiological response to exercise (e.g., beta blockers)
  • Prescription medication with a known side effect of impaired temperature regulation or fluid balance (e.g., diuretics)
  • Positive pregnancy test at any time during the study or breast feeding
  • Current tobacco or electronic cigarette use or consistent use within the last 2 years
  • Inability to safely complete the peak oxygen uptake test

Trial locations and contacts

1 site in 1 country.

United States1 site
  • School of Public Health

    Bloomington, Indiana, 47405-7109

Other trials in United States

About this study

An epidemic of chronic kidney disease is occurring in laborers who undertake physical work outdoors in hot conditions. The reason for this is unknown, but may be related to kidney dysfunction caused by increases in body temperature and dehydration. The current heat stress recommendations for workers were not developed with regards for kidney health. The purpose of this study is to determine if the current recommendations protect against kidney dysfunction.

Being tested
23.0°C WBGT - Fixed Work Rate, 25.5°C WBGT - Fixed Work Rate, 27.5°C WBGT - Fixed Work Rate, 28.5°C WBGT - Fixed Work Rate, 35.5°C WBGT - Fixed Work Rate
Medical subject headings
Hyperthermia, Dehydration

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • 23.0°C WBGT - Fixed Work RateOther

    For four hours, participants will walk on a treadmill to elicit 430 W of metabolic heat production in the following conditions:

    23.0°C WBGT (29°C, 46% relative humidity) @ 60 min exercise per hour

  • 25.5°C WBGT - Fixed Work RateOther

    For four hours, participants will walk on a treadmill to elicit 430 W of metabolic heat production in the following conditions:

    25.5°C WBGT (31°C, 52% relative humidity) @ 45 min exercise per hour

  • 27.5°C WBGT - Fixed Work RateOther

    For four hours, participants will walk on a treadmill to elicit 430 W of metabolic heat production in the following conditions:

    27.5°C WBGT (33°C, 53% relative humidity) @ 30 min exercise per hour

  • 28.5°C WBGT - Fixed Work RateOther

    For four hours, participants will walk on a treadmill to elicit 430 W of metabolic heat production in the following conditions:

    28.5°C WBGT (34°C, 54% relative humidity) @ 15 min exercise per hour

  • 35.5°C WBGT - Fixed Work RateOther

    For four hours, participants will walk on a treadmill to elicit 430 W of metabolic heat production in the following conditions:

    35.5°C WBGT (40°C, 65% relative humidity) @ 15 min exercise per hour

  • 26.0°C WBGT - Fixed work-to-rest ratioOther

    For four hours, participants will walk on a treadmill at differing levels of metabolic heat production and environmental conditions (noted below), but at a fixed work-rest ratio of 30 minutes per hour.

    26.0°C WBGT (31°C, 55% relative humidity) @ 530 W metabolic heat production

  • 30.5°C WBGT - Fixed work-to-rest ratioOther

    For four hours, participants will walk on a treadmill at differing levels of metabolic heat production and environmental conditions (noted below), but at a fixed work-rest ratio of 30 minutes per hour.

    30.5°C WBGT (36°C, 55% relative humidity) @ 230 W metabolic heat production

  • 30.5°C WBGT - Fixed work-to-rest ratio (high intensity)Other

    For four hours, participants will walk on a treadmill at differing levels of metabolic heat production and environmental conditions (noted below), but at a fixed work-rest ratio of 30 minutes per hour.

    30.5°C WBGT (36°C, 55% relative humidity) @ 530 W metabolic heat production

Study groups in NCT04767347
Study groupRoleWhat they receive
Fixed Work RateExperimentalParticipants will walk on a treadmill at 3 mph and the grade will be adjusted to elicit 430 W of metabolic heat production (the most common work intensity). This study will systematically examine the NIOSH recommendations for prescribing work-to-rest ratios with increasing environmental heat stress (defined as Wet Bulb Globe Temperature, WBGT) at this fixed rate of metabolic heat production on kidney function.
Receives: Other: 23.0°C WBGT - Fixed Work Rate; Other: 25.5°C WBGT - Fixed Work Rate; Other: 27.5°C WBGT - Fixed Work Rate; Other: 28.5°C WBGT - Fixed Work Rate; Other: 35.5°C WBGT - Fixed Work Rate
Fixed work-to-rest ratioExperimentalThis study will systematically examine the NIOSH recommendations on changes in kidney function when the work-to-rest ratio is fixed at 30 min per hour (the most commonly prescribed work-to-rest ratio), but the rate of metabolic heat production and environmental heat stress differs (Figure 2). As described in Study 1, the appropriate rate of metabolic heat production will be elicited by having participants walk on a treadmill at 3 mph and the grade will be adjusted accordingly.
Receives: Other: 26.0°C WBGT - Fixed work-to-rest ratio; Other: 30.5°C WBGT - Fixed work-to-rest ratio; Other: 30.5°C WBGT - Fixed work-to-rest ratio (high intensity)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Peak urinary [IGFBP7•TIMP-2]

    Kidney injury marker

    Measured: through study completion, up to 20 weeks

Secondary outcomes (7)
  1. Urinary NGAL

    Kidney injury marker

    Measured: through study completion, up to 20 weeks

  2. Urinary IGFBP7

    Kidney injury marker

    Measured: through study completion, up to 20 weeks

  3. Urinary TIMP-2

    Kidney injury marker

    Measured: through study completion, up to 20 weeks

  4. Urinary IL-18

    Kidney injury marker

    Measured: through study completion, up to 20 weeks

  5. Urinary L-FABP

    Kidney injury marker

    Measured: through study completion, up to 20 weeks

  6. Renal artery blood velocity

    Index of kidney blood flow

    Measured: through study completion, up to 20 weeks

  7. Segmental artery blood velocity

    Index of kidney blood flow

    Measured: through study completion, up to 20 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Feb 2021
  2. Study start1 Mar 2021
  3. Primary completion4 May 2023
  4. Study completion4 May 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Crossover
Model description
This study will systematically examine the NIOSH recommendations for prescribing work-to-rest ratios during occupational heat stress on kidney function.
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
38 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04767347
Sponsor's protocol ID
1902420140
Acronym
Aim1
Status last verified
Nov 2023
First submitted
17 Feb 2021
Last updated
8 Nov 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Hess HW, Hite MJ, Heikkinen ME, Tarr ML, Tourula E, Johnson BD, Hostler D, Schlader ZJ. Critical Assessment of the Recommended Alert Limit Curves for Occupational Heat Exposure. Am J Ind Med. 2025 Nov;68(11):1004-1012. doi: 10.1002/ajim.70022. Epub 2025 Sep 7.

    PubMed 40914830
  • Hess HW, Baker TB, Tarr ML, Zoh RS, Johnson BD, Hostler D, Schlader ZJ. Occupational Heat Stress Recommendation Compliance Attenuates AKI Risk Compared with a Work-Rest Ratio-Matched, Positive Control Scenario. Kidney360. 2023 Dec 1;4(12):1752-1756. doi: 10.34067/KID.0000000000000288. Epub 2023 Nov 1.

    PubMed 37907448
  • Hess HW, Tarr ML, Baker TB, Hostler D, Schlader ZJ. Ad libitum drinking prevents dehydration during physical work in the heat when adhering to occupational heat stress recommendations. Temperature (Austin). 2022 Jul 20;9(3):292-302. doi: 10.1080/23328940.2022.2094160. eCollection 2022.

    PubMed 36211944

Questions about this trial

What is this clinical trial studying?

A study testing 23.0°C WBGT - Fixed Work Rate, 25.5°C WBGT - Fixed Work Rate and 27.5°C WBGT - Fixed Work Rate in people with Hot Weather; Adverse Effect and Kidney Dysfunction, run by Indiana University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Nov 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Peak urinary [IGFBP7•TIMP-2] (time frame: through study completion, up to 20 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04767347, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Nov 2023; AzTrials last refreshed its copy on 6 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in